StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Anbio Biotechnology Class A Ordinary Shares
NasdaqGM:NNNN
Sector
Location
Market Cap
USD 2.23 B
Share Price
USD 50.73
Avg Daily Volume
89,745
Change (1 day)
-2.08%
Change (1 year)
Change (YTD)
553.80%
Anbio Biotechnology Class A Ordinary Shares Operating Cash Flow for the year ending December 31, 2024: USD 2.08 M
Anbio Biotechnology Class A Ordinary Shares Operating Cash Flow is USD 2.08 M for the year ending December 31, 2024, a 131.57% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Anbio Biotechnology Class A Ordinary Shares Operating Cash Flow for the year ending December 31, 2023 was USD 898.37 K, a -79.81% change year over year.
-
Anbio Biotechnology Class A Ordinary Shares Operating Cash Flow for the year ending December 31, 2022 was USD 4.45 M.
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
MERCK Kommanditgesellschaft auf Aktien
USD 133.90
MRK.DE
+3.46
2.66%
Agilent Technologies, Inc.
USD 124.17
A
+2.87
2.37%
Qiagen N.V.
USD 48.55
QGEN
+0.59
1.23%
Aurobindo Pharma Limited
USD 13.19
AUROPHARMA.NS
+0.02
0.14%
Repligen Corporation
USD 134.00
RGEN
+4.18
3.22%
Bruker Corporation
USD 43.58
BRKR
+1.46
3.47%
Yuhan Corporation
USD 81.27
000100.KS
+2.21
2.80%
Pharmaron Beijing Co., Ltd.
USD 2.35
3759.HK
+0.20
9.26%
Bachem Holding AG
USD 72.62
BANB.SW
+0.87
1.21%
Siegfried Holding AG
USD 112.68
SFZN.SW
+0.12
0.10%
Gan & Lee Pharmaceuticals.
USD 7.74
603087.SS
+0.08
1.09%
Cohance Lifesciences Limited
USD 11.67
COHANCE.NS
+0.06
0.50%
Metsera, Inc.
USD 36.41
MTSR
+1.09
3.09%
Bloomage BioTechnology Corporation Limited
USD 7.19
688363.SS
+0.04
0.62%
Syngene International Limited
USD 7.36
SYNGENE.NS
-0.04
-0.53%
Beijing Hotgen Biotech Co., Ltd.
USD 26.49
688068.SS
+0.87
3.41%
Jafron Biomedical Co.,Ltd.
USD 3.15
300529.SZ
-0.01
-0.38%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.28
300009.SZ
+0.06
4.54%
Changzhou Qianhong Biopharma CO.,LTD
USD 1.33
002550.SZ
+0.09
7.18%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 46.66
4519.T
-0.22
-0.47%
MERCK Kommanditgesellschaft auf Aktien
USD 133.90
MRK.DE
+3.46
2.66%
Agilent Technologies, Inc.
USD 124.17
A
+2.87
2.37%
Qiagen N.V.
USD 48.55
QGEN
+0.59
1.23%
Aurobindo Pharma Limited
USD 13.19
AUROPHARMA.NS
+0.02
0.14%
Repligen Corporation
USD 134.00
RGEN
+4.18
3.22%
Bruker Corporation
USD 43.58
BRKR
+1.46
3.47%
Yuhan Corporation
USD 81.27
000100.KS
+2.21
2.80%
Pharmaron Beijing Co., Ltd.
USD 2.35
3759.HK
+0.20
9.26%
Bachem Holding AG
USD 72.62
BANB.SW
+0.87
1.21%
Siegfried Holding AG
USD 112.68
SFZN.SW
+0.12
0.10%
Gan & Lee Pharmaceuticals.
USD 7.74
603087.SS
+0.08
1.09%
Cohance Lifesciences Limited
USD 11.67
COHANCE.NS
+0.06
0.50%
Metsera, Inc.
USD 36.41
MTSR
+1.09
3.09%
Bloomage BioTechnology Corporation Limited
USD 7.19
688363.SS
+0.04
0.62%
Syngene International Limited
USD 7.36
SYNGENE.NS
-0.04
-0.53%
Beijing Hotgen Biotech Co., Ltd.
USD 26.49
688068.SS
+0.87
3.41%
Jafron Biomedical Co.,Ltd.
USD 3.15
300529.SZ
-0.01
-0.38%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.28
300009.SZ
+0.06
4.54%
Changzhou Qianhong Biopharma CO.,LTD
USD 1.33
002550.SZ
+0.09
7.18%